According to BioLineRx's latest financial reports the company's current earnings (TTM) are -$58.48 M. a decrease over its 2022 earnings that were of -$23.17 M.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Year | Earnings | Change |
---|---|---|
2023 | -$58.48 M | 152.41% |
2022 | -$23.17 M | -11.14% |
2021 | -$26.07 M | -8.69% |
2020 | -$28.56 M | 20.89% |
2019 | -$23.62 M | -7.47% |
2018 | -$25.53 M | 1.12% |
2017 | -$25.24 M | 52.84% |
2016 | -$16.52 M | 1.96% |
2015 | -$16.2 M | 0.84% |
2014 | -$16.07 M | -8.06% |
2013 | -$17.47 M | -20.91% |
2012 | -$22.09 M | |
2010 | $4.23 M |